The Academy of Immuno-Oncology was established by SITC to honor individuals who have launched the field of cancer immunotherapy into the breakthrough cancer treatment it is today and bring together the brightest minds in the field to continue to advance SITC, the field, and the next generation of immuno-oncologists.
Annually, SITC conducts an open call for nominations and inducts a new class of Fellows into the Academy of Immuno-Oncology, one of the society’s most prestigious honors. (Actively serving nomination committee members or Board members are not eligible for nomination.) Fellows of the Academy of Immuno-Oncology bear the designation “FAIO.”